14 reports

  • SMALL MOLECULES TO INHIBIT DXR FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE
  • SMALL MOLECULES TO INHIBIT HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE
  • Malaria
  • Research And Development
  • United States
  • Product Initiative
  • Sanaria Inc.
  • SMALL MOLECULES TO INHIBIT DXR FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE
  • SMALL MOLECULES TO INHIBIT HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE
  • Malaria
  • Research And Development
  • United States
  • World
  • Product Initiative
  • Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma
  • Malaria
  • Medical Equipment
  • Japan
  • United States
  • Eisai Co., Ltd.
  • DEC 02, 2016: ACCESS BIO RECIEVED A USD $3.7 MILLION GRANT FROM THE BILL & MELINDA GATES FOUNDATION

Although the CAAD s development programs are focused on improved diagnostic approaches for diseases such as malaria, HIV and tuberculosis, these efforts are also expected to yield significant advances in point-of-care testing for infections that burden high-income countries, such as influen

  • Infectious Disease
  • Malaria
  • Molecular Diagnostic
  • South Korea
  • GlobalData's company

The organization offers HIV and AIDS, influenza, malaria and tuberculosis care services.

  • Malaria
  • Pharmaceutical
  • Vaccine
  • United States
  • GlobalData's company
  • Eisai Co., Ltd. - Discovery, 2016
  • Malaria
  • R&D
  • Research And Development
  • United States
  • Eisai Co., Ltd.
  • Medicines for Malaria Venture, Key Competitors
  • Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab
  • Malaria
  • Pharmaceutical
  • United States
  • Company Operations
  • GlobalData's company
  • THROMBOSIS
  • ASTRAZENECA PLC - DISCOVERY, 2016

The scientists reported ##, ##-azaindoles as a new inhibitor class that killed Mycobacterium tuberculosis in vitro and demonstrated efficacy in mouse tuberculosis models.

  • Cancer
  • Malaria
  • Therapy
  • United States
  • AstraZeneca PLC
  • FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS, MAJOR PRODUCTS AND SERVICES

FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions.

  • Diagnostics
  • Infectious Disease
  • Malaria
  • Africa
  • GlobalData's company

HIV/ AIDS is the leading cause of deaths of over ##. ## million people every year; and malaria and tuberculosis together cause deaths of an estimated ##. ## million people.

  • Gene Therapy
  • Malaria
  • Vaccine
  • United States
  • GenVec, Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Tuberculosis Patients: A Single Centre Non- Randomized Trial Effect of Malaria Prevention on In-Hospital Mortality among Severely Ill Tuberculosis Patients GDCT## ISRCTN##, Infectious Disease Malaria, Tuberculosis Completed Phase II Interventional (trimethoprim

  • Clinical Trial
  • Malaria
  • Therapy
  • World
  • GlaxoSmithKline plc
  • INFECTION DETECTION TEST - P. FALCIPARUM - PRODUCT DESCRIPTION
  • INFECTION DETECTION TEST - P. FALCIPARUM - PRODUCT STATUS

FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions.

  • Clinical Trial
  • Malaria
  • Point Of Care Testing
  • United States
  • GlobalData's company
  • Cellceutix Corporation - Dormant Developmental Projects,2016
  • Malaria
  • R&D
  • Research And Development
  • United States
  • Cellceutix Corporation
  • Official Title
  • Clinical Trial Profile Snapshots
  • Clinical Trial
  • Infectious Disease
  • Malaria
  • World
  • GlaxoSmithKline plc